AB Science announces that masitinib study in primary and secondary progressive forms of multiple sclerosis has passed its non-futility test at 2 years The study has completed patient recruitment ...
The patent comes months after Immunic Therapeutics announced CALLIPER study results, which tested vidofludimus calcium in ...
More than 20 years ago, as Jennifer Digmann focused on completing her coursework and graduating from college, she began experiencing numbness in her hands and feet and eventually double vision. After ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop treatments ...
The role of imaging in diagnosing progressive multiple sclerosis (MS) and in assessing prognosis is the subject of a new review. MRI is central in the diagnostic workup of patients suspected of having ...
In relapse-remitting multiple sclerosis (MS), people experience periods of high MS activity where they have more symptoms or imaging tests show inflammation. Between these periods, the condition might ...
Following a diagnosis, a Pennsylvania woman underwent genetic testing that revealed she had a very rare, inherited form of ...
Pittsburgh Public Schools is turning to more progressive methods of discipline, after finding that cut and dry methods, like Zero Tolerance, led to too many suspensions. Back in the ‘90s, many schools ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback